![]() |
HER2-positive metastatic breast cancer women benefit from trastuzumab and chemotherap
The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.
More... |
| All times are GMT -7. The time now is 08:06 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021